This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Piergiuseppe Nestola, PhD
Manager of Process Technology at Sartorius Stedim Switzerland AG


Piergiuseppe Nestola, PhD, is a Manager of Process Technology Consultants at Sartorius where he is responsible for providing scientific, technological and process leadership in the field of viral-based and nucleic acid therapeutics . He holds a PhD degree in Chemical and Biochemical Engineering from Universidade Nova de Lisboa (PT), where he developed virus purification processes for vaccines and gene therapies. Before joining Sartorius Piergiuseppe worked for several years at Janssen Vaccines AG in Bern (CH) as a scientist and team leader in the process development group. He was involved in developing and scaling up both viral vectors and protein-based vaccines in this role. Piergiuseppe has also been a judge at the Mass challenge and Bioexpert network incubators since 2018, supporting start-up life science companies.

Agenda Sessions

  • Oligonucleotides, A New Renaissance: Challenges and Solutions